Recruiting
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
NCT06583070
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
- Peking University Third Hospital Beijing, Beijing Municipality, China